We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+23.34%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$1.06B
AUM Growth
+$217M
Cap. Flow
+$46.1M
Cap. Flow %
4.35%
Top 10 Hldgs %
19.28%
Holding
1,042
New
162
Increased
350
Reduced
349
Closed
87

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 10.07%
3 Consumer Discretionary 9.06%
4 Financials 7.61%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIEN
901
DELISTED
Sientra, Inc.
SIEN
$45K ﹤0.01%
+1,150
New +$34.7K
ACGN
902
DELISTED
Aceragen Inc
ACGN
$45K ﹤0.01%
+1,490
New +$46K
KDNY
903
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$45K ﹤0.01%
+3,889
New +$53.6K
CLSD
904
DELISTED
Clearside Biomedical
CLSD
$43K ﹤0.01%
1,527
CPIX icon
905
Cumberland Pharmaceuticals
CPIX
$99M
$43K ﹤0.01%
+13,041
New +$47.4K
GASS icon
906
StealthGas
GASS
$328M
$43K ﹤0.01%
15,600
IBIO icon
907
iBio
IBIO
$71M
$42K ﹤0.01%
+38
New +$24.9K
NURO
908
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$42K ﹤0.01%
+2,575
New +$44.4K
EMWP
909
DELISTED
Eros Media World PLC
EMWP
$41K ﹤0.01%
+650
New +$36.7K
ENDP
910
DELISTED
Endo International plc
ENDP
$37K ﹤0.01%
+10,774
New +$41.3K
OXSQ icon
911
Oxford Square Capital
OXSQ
$151M
$35K ﹤0.01%
12,600
SNGX icon
912
Soligenix
SNGX
$5.5M
$35K ﹤0.01%
+69
New +$28.4K
ADAM
913
Adamas Trust
ADAM
$777M
$34K ﹤0.01%
3,300
-13,100
-80% -$115K
TRT
914
Trio-Tech International
TRT
$93.3M
$33K ﹤0.01%
20,818
CETX icon
915
Cemtrex
CETX
$4.65M
0
MFA
916
MFA Financial
MFA
$929M
$31K ﹤0.01%
3,150
TRIB
917
Trinity Biotech
TRIB
$5.7M
$31K ﹤0.01%
+93
New +$21.3K
TXMD icon
918
TherapeuticsMD
TXMD
$23.8M
$30K ﹤0.01%
+480
New +$27.9K
NTBL
919
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$29K ﹤0.01%
+643
New +$29K
TRVN
920
DELISTED
Trevena, Inc.
TRVN
$28K ﹤0.01%
+30
New +$20K
DSWL icon
921
Deswell Industries
DSWL
$55.3M
$27K ﹤0.01%
11,100
OGI
922
Organigram Holdings
OGI
$132M
$27K ﹤0.01%
4,400
ELGX
923
DELISTED
Endologix Inc
ELGX
$27K ﹤0.01%
34,200
-3,417
-9% -$2.89K
TPST icon
924
Tempest Therapeutics
TPST
$14.8M
$26K ﹤0.01%
77
+13
+20% +$5.19K
QBAK
925
DELISTED
Qualstar Corp
QBAK
$25K ﹤0.01%
10,227
-5,466
-35% -$11K

Similar funds

Wedbush Securities's Q2 2020 Portfolio in Review

As of Q2 2020, Wedbush Securities held 1,042 positions worth $1.06B, up 26% from $840M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Wedbush Securities deployed $46.1M of net new capital in Q2 2020, opening 162 new positions and adding to 350 existing holdings. Its largest new stake was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $4.65M trimmed.

  • Wedbush Securities's largest Q2 2020 buy was Vanguard ESG US Stock ETF: 127,200 shares worth $7.17M.
  • Wedbush Securities added most to First Trust Enhanced Short Maturity ETF in Q2 2020, an estimated $5.29M increase.
  • Wedbush Securities's biggest Q2 2020 reduction was Vanguard Total Stock Market ETF, cutting an estimated $4.65M.
  • Wedbush Securities fully exited Pacer Trendpilot US Large Cap ETF in Q2 2020, selling an estimated $1.36M.
  • Wedbush Securities's ten largest holdings make up 19% of its $1.06B portfolio in Q2 2020.
  • Wedbush Securities opened 162 new positions and closed 87 in Q2 2020.
  • Wedbush Securities's portfolio value rose 26% quarter-over-quarter to $1.06B.

Based on Wedbush Securities's 13F filing for Q2 2020, filed 16 Jul 2020.